Latest News

Healthy figures from Spain

© pixabay.com/travelkr


by um

At BioEquity 2019, Spanish Bioindustry Association ASEBIO has given a sneak peek into its 2018 Annual Report, that each year describes the news and trends from the Spanish Biotech Sector.

The early data suggests that 2018 was a year of historically high specialised investment in biotechnology. More than €94m of private capital were raised in this time period, which marks an 1%-increase compared to 2017. And all signs point to growth: this is the third consecutive year of investment growth in the sector.

2018 also stands out for two corporate transactions made by foreign companies. First, TiGenix was purchased by Takeda for €520m, and Qiagen took over Stat-Dx for €150m. “Unprecedented in our country”, commented ASEBIO.

In terms of geographical investment, Catalonia is the Autonomous Community with the second highest number of biotechnology companies created, with nine businesses in total. Over the last ten years, the region has always been in first or second place in the national ranking.

The full 2018 report will be published in late June.

SeaBeLife secures €1.2m in funding

SeaBeLife SAS has secured €1.2m in funding, aiming to develop unique drug candidates that block cell necrosis and target two regulated cell death...

Xlife Sciences AG acquires 20% stake in 4D Lifetec AG

Aboleris Pharma bags €27.3m in Series A Financing

AbolerIS Pharma SA’s financing was led by  Caixa Capital Risc and co-led by Sound Bioventures and existing investor Newton Biocapital with...

Study links TCM with effects on protein networks

The framework, validated with hospital patient data, is among the first to provide a scientific foundation to evaluate the therapeutic efficacy of...

Agomab Therapeutics NV raises US$100m in Series C financing

The closed financing round was led by Fidelity Management & Research Company. New investors EQT Life Sciences, Canaan and Dawn Biopharma/KKR, as...

microRNA could offer a safe target in atherosclerosis

The researcher demonstrateded that targeting of miR-206-3p with an experimental compound safely reversed the onset of atherosclerosis in a...

Researchers stop brain cell death in Alzheimer’s mice

The research team led by Prof. Bart De Strooper (VIB-KU Leuven/UK Dementia Research Institute), and Dr Sriram Balusu (VIB-KU Leuven) has finally...